FDA Drug recall D-111-2013
Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center,…
- FDA Drug
- Class I
- terminated
- Published 2013-01-09
On 2013-01-09 the FDA classified a Class I recall of Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center,… by New England Compounding Center, citing non-Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-111-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2012-09-26 |
| Published | 2013-01-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | New England Compounding Center |
| Distribution | US |
Product
Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Reason
Non-Sterility
Identifiers
| code_info | All lot codes |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-111-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.